Allurion’s weight loss balloon back on French market
Seven months after suspending sales of its weight loss balloon in France due to safety concerns, Allurion’s products are back …
Seven months after suspending sales of its weight loss balloon in France due to safety concerns, Allurion’s products are back …
Yourgene Health, a molecular diagnostics group within the Novacyt group of companies, has announced the UK launch of a fully …
InspireMD, in partnership with NAMSA, is set to initiate the pivotal, single-arm CGUARDIANS II study to assess the CGuard Prime …
Preventative health startup Prenuvo, which offers a full-body MRI scan technology lauded by celebrities, has raised $120m in funding. The US-based …
Artera and Tempus are collaborating to expand access to Artera’s AI-based prostate cancer test. Currently connected to more than 50% of …
Grail has partnered with Quest Diagnostics to enable access to its Galleri multi-cancer early detection test for healthcare providers in …
Newronika has completed a €13.6m ($14.1m) Series B funding to advance the development of AlphaDBS, an adaptive deep brain stimulation …
QuantalX Neuroscience has gained the European CE Medical Device Regulation (MDR) approval for the Delphi-MD, a device for assessing brain …
Getinge plans to phase out its surgical perfusion business in a move expected to benefit major players such as LivaNova, …
Thermo Fisher Scientific has launched the Invitrogen Evos S1000 spatial imaging system, which enables researchers to produce quality data. This system …
Germitech has raised $30m in a financing round to hasten the reach of the company’s footprint in the US disinfection …
US-based Children’s National Hospital and medical device company Compremium are partnering to develop non-invasive pressure monitoring technologies for paediatric patients. Based …
Siemens Healthineers and Cubresa have entered a global master interface agreement, focusing on the development and compatibility assessment of the …
Bank of America (BofA) forecasts that Medtronic will exceed its topline organic revenue growth expectations of 4.75% ahead of the …
Stryker has agreed to sell its US spinal implants business to the Viscogliosi Brothers. The newly formed company will be …